ACADIA Pharmaceuticals Inc.
ACADNASDAQHealthcare● Active
$21.70
+$0.14(+0.65%)
Market Cap$3.7B
P/E Ratio—
52W High$28.35
52W Low$19.69
ACADIA Pharmaceuticals Inc. (ACAD) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ACAD · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.82B | $0.76B | $0.44B | $0.42B | $0.52B |
| Net Receivables | $0.15B | $0.10B | $0.10B | $0.06B | $0.07B |
| Inventory | $0.03B | $0.02B | $0.04B | $0.01B | $0.01B |
| Total Current Assets | $1.06B | $0.94B | $0.62B | $0.51B | $0.62B |
| PP&E Net | $0.05B | $0.05B | $0.06B | $0.06B | $0.07B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.11B | $0.12B | $0.07B | $0.00B | $0.00B |
| Total Assets | $1.56B | $1.19B | $0.75B | $0.59B | $0.70B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.01B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.02B | $0.02B | $0.01B | $0.01B |
| Total Current Liabilities | $0.28B | $0.39B | $0.25B | $0.13B | $0.10B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.34B | $0.45B | $0.32B | $0.19B | $0.16B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.81B) | ($2.20B) | ($2.43B) | ($2.37B) | ($2.15B) |
| Total Stockholders Equity | $1.23B | $0.73B | $0.43B | $0.40B | $0.54B |
| Total Liab & Equity(computed) | $1.56B | $1.19B | $0.75B | $0.59B | $0.70B |
| Debt Summary | |||||
| Total Debt | $0.05B | $0.05B | $0.06B | $0.06B | $0.06B |
| Net Debt | ($0.13B) | ($0.27B) | ($0.13B) | ($0.05B) | ($0.08B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more ACADIA Pharmaceuticals Inc. data
About ACADIA Pharmaceuticals Inc. (ACAD) Balance Sheet
ACADIA Pharmaceuticals Inc. (ACAD) balance sheet shows total assets of $1.56B with cash of $0.82B. Total liabilities are $0.34B, total debt $0.05B, and stockholders equity $1.23B.
Frequently asked questions
ACAD · 4 questionsACADIA Pharmaceuticals Inc. has total debt of $0.05B with net debt of ($0.13B).
ACAD total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10